why choose us

First received: January 18, 2024

Clinical Trial: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-label, Single Dose, Two-way Replicate Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of &qu

Brief Summary: The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-1" and "BR1019-2" in healthy volunteers

Read more